Soleno Therapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
07.10.25
/
50%
€54.00
Target price
07.10.26
€106.85
Performance (%)
-23.26%
Price
23.12.25
€41.06
Summary
This prediction is currently active. The price of Soleno Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.26%. This prediction currently runs until 07.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -1.346% | -1.346% |
| iShares Core DAX® | 0.765% | 4.791% |
| iShares Nasdaq 100 | 1.418% | 3.133% |
| iShares Nikkei 225® | 0.658% | 0.972% |
| iShares S&P 500 | 1.310% | 2.279% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) was given a new $125.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat